Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response

Published 2017 View Full Article

Authors

Keywords

neuroendocrine tumors; MGMT; temozolomide; capecitabine; immunohistochemistry

Journal

Oncotarget

Volume 8, Issue 61, Pages -

Publisher

Impact Journals, LLC

Online

2017-10-25

DOI

10.18632/oncotarget.22001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started